SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-034175
Filing Date
2024-03-20
Accepted
2024-03-20 16:15:13
Documents
11
Period of Report
2024-03-19
Items
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

Document Format Files

Seq Description Document Type Size
1 8-K ubx-20240319.htm   iXBRL 8-K 44583
  Complete submission text file 0000950170-24-034175.txt   159889

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT ubx-20240319.xsd EX-101.SCH 26518
14 EXTRACTED XBRL INSTANCE DOCUMENT ubx-20240319_htm.xml XML 4538
Mailing Address 285 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 285 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 416-1192
Unity Biotechnology, Inc. (Filer) CIK: 0001463361 (see all company filings)

IRS No.: 264726035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38470 | Film No.: 24767969
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)